Lakewood-Amedex Inc. today announced that Douglas Manion, M.D., FRCP (C), who has served as a board director since 2021, was named Chairman of the Board of Directors. Dr. Manion is currently the Chief Executive Officer, and Director, Flare Therapeutics....
Lakewood-Amedex Inc. today announced that Peter B. Corr, Ph.D., who has served as board chairman since 2020, was named Executive Chairman and will assume the strategic responsibilities of former CEO Steve Parkinson....
Elects Thomas Pfisterer and Douglas Manion, MD, FRCP(C), to the Board of Directors SARASOTA, Fla., January 25, 2022 — Lakewood-Amedex Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called Bisphosphocins®, today announced that two new...
Lakewood-Amedex Therapeutics Inc. today announced that Peter B. Corr, Ph.D., has been elected as Chairman of the Board of Directors of the company. Dr. Corr assumes the role from Steve Parkinson, who continues to serve as President and CEO....